NovaBridge Biosciences Increase (Decrease) in Other Noncurrent Liabilities
NovaBridge Biosciences (NBP) reported Increase (Decrease) in Other Noncurrent Liabilities of $512.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-04-07
- NovaBridge Biosciences increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was -959.00K CNY.
CNY
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -6.21M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 2.03M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | -986.00K CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 5.96M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | -2.77M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | -959.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 7.47M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 8.43M CNY 6-K · filed 2021-02-05 |
USD
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $512.00K 20-F · filed 2026-04-07 | ||||
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | -$106.00K 20-F · filed 2026-04-07 | ||
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | -$106.00K 6-K · filed 2025-12-18 | |||
| 2024-06-30 | -$106.00K 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | -$894.00K 20-F · filed 2026-04-07 | -$875.00K 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $226.00K 20-F · filed 2025-04-03 | $294.00K 20-F · filed 2023-05-01 | |||
| 2022-06-30 | -$147.00K 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $935.00K 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | -$97.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $1.15M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $1.24M 6-K · filed 2021-02-05 |